Telix Pharmaceuticals LimitedASX: TLX

Historical Financials in USD and H12025 OPEX (Unaudited)

· Issued by Telix Pharmaceuticals Limited

Filed with ASX · · 10 pages · English

Summary by 6ix AI

Telix Pharmaceuticals Limited has released an unaudited recast of its historical financial information in USD, following a change in reporting currency from Australian dollars, to assist investors with upcoming financial reports. The recast includes full-year and half-year information for the previous two financial years to facilitate comparisons with future results. Additionally, the filing outlines expected operating expenditure for the first half of the upcoming year, reflecting the company's expanded business activities. This announcement serves to provide clarity on financial performance as Telix transitions to USD reporting.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Telix Pharmaceuticals Limited on 6ix

Earlier from Telix Pharmaceuticals

Later from Telix Pharmaceuticals

All Telix Pharmaceuticals news releases